Measures of drug toxicity in older adults

Archives of Internal Medicine

Volumn 168, Issue 17, 2008, Pages 1930-1931

  Hilmer, Sarah N ^a   Abernethy, Darrell R ^b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; SEDATIVE AGENT;

ANTICHOLINERGIC EFFECT; COMORBIDITY; DATA BASE; DOSE RESPONSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG INTOXICATION; DRUG SAFETY; GERIATRIC CARE; HUMAN; LETTER; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT;

AGED; DRUG THERAPY; FRAIL ELDERLY; HUMANS;

EID: 52649107666     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508-513.
2. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81(2):235-241.
3. Gray SL, Penninx BW, Blough DK, et al. Benzodiazepine use and physical performance in community-dwelling older women. J Am Geriatr Soc. 2003;51(11):1563-1570.
4. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781-787.
5. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83(3):422-429.